Bicocca Open Archive

Logo unimib boa
MASSERINI, MASSIMO ERNESTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.593
EU - Europa 7.638
AS - Asia 3.344
SA - Sud America 241
AF - Africa 56
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 24
Totale 24.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.226
DE - Germania 1.337
CN - Cina 1.317
IT - Italia 1.202
SE - Svezia 1.132
SG - Singapore 1.012
RU - Federazione Russa 983
IE - Irlanda 870
UA - Ucraina 688
GB - Regno Unito 439
HK - Hong Kong 422
CA - Canada 344
FI - Finlandia 233
BR - Brasile 201
IN - India 190
FR - Francia 155
PL - Polonia 131
VN - Vietnam 113
AT - Austria 105
DK - Danimarca 84
BE - Belgio 68
IR - Iran 60
NL - Olanda 58
TR - Turchia 43
BG - Bulgaria 36
ZA - Sudafrica 28
ID - Indonesia 27
JP - Giappone 27
KR - Corea 26
ES - Italia 24
PT - Portogallo 24
AU - Australia 23
EU - Europa 23
MX - Messico 19
TW - Taiwan 16
CH - Svizzera 15
CZ - Repubblica Ceca 15
RO - Romania 13
CL - Cile 12
IL - Israele 11
AR - Argentina 10
EG - Egitto 10
IQ - Iraq 8
MY - Malesia 8
PK - Pakistan 8
BD - Bangladesh 6
EC - Ecuador 6
HU - Ungheria 6
TH - Thailandia 6
VE - Venezuela 6
GR - Grecia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
LB - Libano 4
MA - Marocco 4
NZ - Nuova Zelanda 4
JO - Giordania 3
LT - Lituania 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
MU - Mauritius 3
NO - Norvegia 3
YE - Yemen 3
AO - Angola 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CO - Colombia 2
ET - Etiopia 2
GE - Georgia 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PY - Paraguay 2
QA - Qatar 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
CY - Cipro 1
DO - Repubblica Dominicana 1
HN - Honduras 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
NG - Nigeria 1
SC - Seychelles 1
Totale 24.923
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.238
Woodbridge 1.577
Chandler 1.058
Houston 864
Dublin 846
Fairfield 832
Jacksonville 751
Frankfurt am Main 727
Singapore 649
Ashburn 645
Wilmington 610
Dearborn 596
Milan 541
Hong Kong 397
Seattle 385
Santa Clara 324
New York 311
Cambridge 293
Princeton 278
Nanjing 223
Beijing 188
Shanghai 164
Lachine 127
Kraków 114
Lawrence 110
Altamura 103
Toronto 98
Helsinki 92
Vienna 91
Moscow 84
Nanchang 82
Guangzhou 80
Council Bluffs 77
Hangzhou 69
Boardman 68
Ottawa 66
San Diego 66
Brussels 62
Dong Ket 55
Andover 51
Changsha 50
Fremont 49
Tianjin 44
Los Angeles 43
Shenyang 43
Wayne 43
Falls Church 38
Hebei 36
Jiaxing 36
Jinan 36
Plovdiv 36
Mountain View 31
Nürnberg 31
Rome 31
Hefei 29
Zhengzhou 28
Auburn Hills 27
Kunming 27
Norwalk 24
Chicago 23
Jakarta 23
The Dalles 23
Grafing 21
London 21
Ningbo 21
Dallas 20
Huizen 20
Redmond 20
Pune 19
Montréal 16
São Paulo 16
Düsseldorf 14
Edmonton 14
New Delhi 14
Taizhou 14
Lecco 13
Munich 13
Detroit 12
San Mateo 12
Stockholm 12
Taipei 12
Ahmedabad 11
Brooklyn 11
Monmouth Junction 11
Nuremberg 11
Washington 11
Amsterdam 10
Fuzhou 10
Leawood 10
Segrate 10
University Park 10
Zanjan 10
Boston 9
Lauterbourg 9
Palermo 9
Philadelphia 9
Porto 9
Brno 8
Copenhagen 8
Kiev 8
Totale 17.231
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 525
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 364
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 351
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 348
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 343
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 314
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 304
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 301
Nanomedicine for the treatment of Alzheimer's disease 291
Morphogenic effect of common solvent in the self-assembly behavior of amphiphilic PEO-b-PLA 290
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 278
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 269
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 268
Enhanced brain targeting of engineered solid lipid nanoparticles 267
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 267
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 267
Versatile and Efficient Targeting Using a Single Nanoparticulate Platform and its Application to Cancer and Alzheimer's Disease 265
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 254
TrkA pathway activation induced by amyloid-beta (Abeta) 251
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 248
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 244
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 243
Curcumin derivatives as new ligands of Aβ peptides 242
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 236
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 230
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 225
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 224
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 220
Effect of modified collagen on amyloid beta peptide aggregation 220
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 218
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 216
Developmental changes in the protein composition of sphingolipid- and cholesterol-enriched membrane domains of rat cerebellar granule cells 214
Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model 213
Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds 212
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 210
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 209
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 206
Inhibition of murine leukemia (WEHI-3B and L1210) proliferation by cholera toxin B subunit 204
Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor 204
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 203
Pin1: a new outlook in Alzheimer's disease 199
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 196
Immunoseparation of Prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cells 195
Interactions of proteins with ganglioside-enriched microdomains on the membrane: the lateral phase separation of molecular species of GD1a ganglioside, having homogeneous long-chain base composition, is recognized by Vibrio cholerae sialidase 195
Role of lipid rafts and GM1 in the segregation and processing of Prion Protein 195
Abnormal cross-talk between mutant presenilin 1 (I143T, G384A) and glycosphingolipid biosynthesis 192
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 189
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 189
Detection and Characterization of Different Brain-Derived Subpopulations of Plasma Exosomes by Surface Plasmon Resonance Imaging 189
Enhanced brain targeting of engineered solid lipid nanoparticles 188
Ceramides and sphingomyelinases in senile plaques 187
Pin1 affects Tau phosphorylation in response to Abeta oligomers 186
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 186
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 185
mApoE-Functionalized Nanoliposomes Delivering Doxorubicin and Ultrasmall Superparamagnetic Iron Oxide to Glioblastoma Cells Characterized by TEM and Confocal Microscopy 183
Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin 182
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 182
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 181
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 180
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 178
ALCOHOL AND NEURAL LIPIDS 176
Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients 176
Dependence of rat liver CMP-N-acetylneuraminate:GM1 sialyltransferase (SAT IV) activity on the ceramide composition of GM1 ganglioside 176
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 176
Role of phosphatidylethanol in membranes. Effects on membrane fluidity, tolerance to ethanol, and activity of membrane-bound enzymes 175
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 175
Two tail-anchored protein variants, differing in transmembrane domain length and intracellular sorting, interact differently with lipids 174
Age-related changes in the ceramide composition of the major gangliosides present in rat brain subcellular fractions enriched in plasma membranes of neuronal and myelin origin 173
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 172
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 171
Nanotechnology for neurodegenerative disorders 171
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 169
Nanomedicine for the treatment of Alzheimer's disease 169
A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface 168
Ischemic conditions and β-secretase activation: The impact of membrane cholesterol enrichment as triggering factor in rat brain endothelial cells 167
Palmitic is the main fatty acid carried by lipids of detergent-resistant membrane fractions from neural and non-neural cells 165
Thermotropic behavior of fatty acid ethyl esters in phospholipid liposomes 164
A surveillance system for early-stage diagnosis of endogenous diseases by swarms of nanobots 164
Methyl-β-cyclodextrin treatment affects the thermotropic behaviour of membranes and detergent-resistant membrane fractions of cultured A431 cells 162
Association to HeLa cells and surface behavior of exogenous gangliosides studied with a fluorescent derivative of GM1 161
Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 161
Effect of curcumin-associated and lipid ligand functionalised nanoliposomes on aggregation of the Alzheimer's Aβ peptide 160
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease 160
Nanotechnology for neurodegenerative disorders 160
Influence of glycolipid oligosaccharide and long-chain base composition on the thermotropic properties of dipalmitoylphosphatidylcholine large unilamellar vesicles containing gangliosides 159
Early-Stage Diagnosis of Endogenous Diseases by Swarms of Nanobots: An Applicative Scenario 158
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 158
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 158
Changes in the composition of detergent-resistant membrane domains of cultured neurons following protein kinase C activation 158
New tricyclic compounds, process for their manufacture and their use as ligands of beta-alyloid peptides 157
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 157
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 157
Raman spectroscopy uncovers biochemical tissue-related features of extracellular vesicles from mesenchymal stromal cells 153
Preparation and use of liposomes for the study of sphingolipid segregation in membrane model systems 152
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications 149
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 147
Self-assembled electrical biodetector based on reduced graphene oxide 145
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 145
Proteomics of plasma membrane microdomains 144
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 144
Totale 20.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020333 0 0 0 0 0 0 0 0 0 0 263 70
2020/20212.536 227 153 286 288 204 165 269 153 236 258 96 201
2021/20221.838 98 167 176 189 76 175 142 100 104 169 158 284
2022/20233.854 449 1.198 338 396 230 562 37 220 260 25 86 53
2023/20242.561 66 84 137 146 328 678 554 121 158 33 37 219
2024/20253.890 244 541 267 214 430 210 259 213 418 716 378 0
Totale 25.611